National Epilepsy Awareness Month: Effective cannabinoid therapies and more
Click Here to Manage Email Alerts
As November is National Epilepsy Awareness Month, Healio has gathered the most recent top stories about the condition that affects 3.4 million Americans each year.
Insights into potential for cannabinoids to treat epilepsy, other seizure-based conditions
Read about the possible therapeutic benefits of cannabinoids and seizure-based conditions from Farhad Sahebkar, MD: Read more.
Phase 2a clinical trial finds adjunctive therapy reduces monthly seizures
Positive results from a phase 2a clinical trial of a novel, oral adjunctive therapeutic to address focal-onset seizures in adults: Read more.
AI-based software helps track adults with epilepsy
News from a Bay Area neurotech firm on an AI-based software algorithm to assist those with status epilepticus: Read more.
White, gray matter on MRI may predict risk for later-onset of epilepsy
MRI-based white, gray matter abnormalities linked to greater risk for late-onset epilepsy, per research presented at ANA: Read more.
No association between pregnancy, seizure reduction
No associations were found between pregnancy and change in catamenial seizure reduction, according to research from ANA: Read more.